Synaptic potentiation requires PARP1 activation: prevailing concepts are revisited. [PDF]
Cohen-Armon M, Segal M.
europepmc +1 more source
AACRNL evolved from virulence factor to epigenetic parasite driving genome expansion in free-living eukaryotes. [PDF]
Xu T, Geng S, Lv X, Xing Q, Sun Y.
europepmc +1 more source
Roles of ADP-Ribosyltransferases in Cancer. [PDF]
Veilleux M, Nguyen A, Cao C, Shi Y.
europepmc +1 more source
Metabolites beyond metabolism: Exploring their atypical roles in protein modification and signaling transduction. [PDF]
Yang W, Wu J, Cui G.
europepmc +1 more source
Therapeutic targeting of post-translational modifications in ovarian cancer: mechanisms and clinical applications. [PDF]
Ke L, Zhang Y.
europepmc +1 more source
Targeting MARylation and DePARylation in Cancer Therapy: New Promising Therapeutic Opportunities. [PDF]
Cabeza-Fernández V +6 more
europepmc +1 more source
A Large-Scale Method to Measure the Stoichiometries of Protein Poly-ADP-Ribosylation. [PDF]
Li P, Zhang Y, Kim C, Yu Y.
europepmc +1 more source
ADP: Ribosylation Factor-Like Tumor Suppressor 1 [PDF]
openaire +1 more source
Deciphering the dark side of histone ADP-ribosylation: what structural features of damaged nucleosome regulate the activities of PARP1 and PARP2. [PDF]
Kurgina TA +4 more
europepmc +1 more source

